Opens in a new tab

Illumina v Element Biosciences (CFI, 16 October 2026)

Date16 October 2026
CourtCFI
DivisionLisbon (PT) Local Division
Type of actionInfringement Action
Case number(s)UPC_CFI_1920/2025, UPC_CFI_1060/2026
Registry referenceUPC-CFI-0001920/2025
PartiesIllumina, Inc. v. Element Biosciences, Inc., Element Biosciences Netherlands B.V., Instrumentos de Laboratório e Científicos, LDA
LanguageEnglish

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 22 October 2026

Our analysis

Summary

By an order of 16 October 2026 following the interim conference (Rule 105.5 RoP), the judge-rapporteur of the Lisbon Local Division, in the dispute between Illumina, Inc. and Element Biosciences, Inc., Element Biosciences Netherlands B.V. and I.L.C. Instrumentos de Laboratório e Científicos Lda (UPC_CFI_1920/2025 and UPC_CFI_1060/2026, EP 3 714 978), set the value of the infringement action at EUR 8,000,000 and that of the counterclaim for revocation at EUR 12,000,000, and laid down the arrangements for the oral hearing to be held in Lisbon on 17 December 2026.

Question

What can the interim conference settle ahead of the oral hearing as regards the value of the dispute, the scope of the claim construction and validity debate, and the conduct of the hearing?

Decision

On the basis of the parties’ agreement, the judge-rapporteur set the value of the infringement action at EUR 8,000,000 and that of the counterclaim for revocation at EUR 12,000,000, giving EUR 20,000,000 for the proceedings as a whole and a ceiling for recoverable costs of EUR 1,200,000 (paras 6 to 8). The claim construction debate is confined to features 1.4.2 and 1.4.7.2, whose reading also determines literal infringement (para 12). Seven validity attacks will be argued, and the admissibility of a new added matter attack raised in the Defendants’ Reply is left to the panel (paras 13 and 14). The number of auxiliary requests, 23 in total, was not considered unreasonable given their structure (para 16). The Claimant must clarify its allegations of direct and indirect infringement within two weeks, with an equal period for the Defendants to respond (para 17 and operative part). The order also sets a timed agenda for the hearing and deadlines for filing presentations and lists of attendees (paras 19 to 25 and operative part).

Key points for practice

Provisions applied

Rules of Procedure
Rules 104, 105, 105.5 and 106 RoP

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 22 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Oral procedure and hearing (UPC), Court fees and costs (UPC), Claim interpretation, Pre-trial phase and pre-trial judge.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
English from the language of proceedings
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_1920/2025 official number
  • UPC_CFI_1060/2026 official number

Follow these proceedings

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 1 April 2026 Illumina v Element Biosciences (CFI, 1 April 2026) Infringement Action · UPC_CFI_1920/2025

    La demande de rejet de l'action fondée sur la règle 361 est rejetée et le mémoire en demande corrigé remplace le mémoire initial, les défenderesses pouvant répondre sous 10 jours.

  2. 22 June 2026 Illumina v Element Biosciences (CFI, 22 June 2026) Infringement Action · UPC_CFI_1920/2025

    La formation instruira ensemble l’action en contrefaçon et la demande reconventionnelle en nullité. La conférence intermédiaire est fixée au 16 octobre 2026 et l’audience au 17 décembre 2026.

  3. 16 October 2026 Illumina v Element Biosciences (CFI, 16 October 2026) Infringement Action · UPC_CFI_1920/2025, UPC_CFI_1060/2026

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
La juge rapporteure fixe la valeur de l'action en contrefaçon à 8 millions d'euros et celle de la demande reconventionnelle en nullité à 12 millions d'euros, et arrête l'organisation de l'audience du 17 décembre 2026.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 714 978Mentioned in the analysis (role not qualified)
Also mentioned in 2 other decision(s): Illumina v Element Biosciences (CFI, 22 June 2026) · Illumina v Element Biosciences (CFI, 1 April 2026)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.